FDA Takes Next Step in Establishing Overseas Presence
By admin - Posted on March 18th, 2008
Agency on path to establish offices in China
March 14, 2008 -- In an important development, the U.S. Food and Drug Administration has received approval from the U.S. State Department to establish eight full time permanent FDA positions at U.S. diplomatic posts in the People's Republic of China, pending authorization from the Chinese government.
This is an important step forward in the FDA's plans to hire and place FDA staff in China over the next 18 months. In addition, the FDA will be hiring a total of five local Chinese nationals to work with the new FDA staff at the U.S. Embassy in Beijing and the U.S. Consulates General in Shanghai and Guangzhou.
"In an age when a border is not a barrier, the globalized economy demands nothing less than heightened regulatory interoperability, information exchange, and cooperation, especially on product quality and enforcement matters," said Murray M. Lumpkin, M.D., deputy commissioner for International and Special Programs, FDA. "Along with the important Memoranda of Agreement signed with two FDA counterpart Chinese agencies, our efforts to fill permanent FDA positions in China are a significant step toward ensuring access to safe food, drugs, and medical devices in the global market."
Building the FDA's capacity outside of the United States supports the agency's "Beyond our Borders" initiative. The initiative facilitates the building of stronger cooperative relationships with the FDA's counterpart agencies around the world and enhanced technical cooperation with foreign regulators. The permanent overseas offices in China will also allow greater access for inspections and greater interactions with manufacturers to help assure that products that are shipped to the United States meet U.S. standards for safety and manufacturing quality.
For additional information on the FDA's international programs, please visit: http://www.fda.gov/oia/overview.html. For more information on the historic Memoranda of Agreement signed in December 2007, between the United States and The People's Republic of China, please visit: http://www.hhs.gov/news/press/2007pres/12/pr20071211a.html.
Source: FDA
Bookmark/Search this post with:
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Login to post comments
Related articles
- FDA Rule and Companion Guidance Make Early Stage Clinical Drug Development Safe and Efficient
- FEMA Supports Federal Aid to China
- Senator Schumer Proposes Track -And-Trace System For Prescription Drugs To Prevent Contamination
- FDA Seeks Civil Penalties from California Device Maker
- FDA Warns Consumers About "Total Body Formula" and "Total Body Mega Formula"
Latest stories
- Statement by Senator Barack Obama on EU Emergency Summit Meeting
- Barack Obama Statement on the Resignation of Japanese Prime Minister Fukuda
- Senator Barack Obama's Statement on the Third Anniversary of Hurricane Katrina
- Statement from Sarah and Todd Palin Regarding Unwed Teen Daughter's Pregnancy
- White House Press Gaggle by Dana Perino and FEMA Administrator Dave Paulison -- September 1, 2008
- Zimbabwe District Calls for Renewed Government Effort on Solar Energy
- Thousands of Anti-War Protesters March to Site of Republican Convention
- US: More than 11,000 Iraqi Detainees Released in 2008
- DoD Identifies Navy Casualty: Petty Officer 1st Class Joshua Harris, 36,of Lexington, North Carolina
- DoD Identifies Army Casualty: Spc. Steven J. Fitzmorris, 26, of Columbia, Missouri
Yes We Can
Yes We Can:
